Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT)

CUSIP: 359664109

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
28,846,139
Total 13F shares
1,449,767
Share change
+34,439
Total reported value
$5,789,004
Price per share
$3.99
Number of holders
18
Value change
+$112,502
Number of buys
8
Number of sells
7

Security key

359664109

Report period

Q1 2018

Institutions

18

Top holders

10

Top shareholders of FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Mutual Advisors, LLC
13F
Company
1.3%
379,411
$1,662,000 31 Dec 2017
13F
Granahan Investment Management, LLC
13F
Company
0.92%
264,621
$1,159,000 31 Dec 2017
13F
Old West Investment Management, LLC
13F
Company
0.74%
212,978
$932,000 31 Dec 2017
13F
VANGUARD GROUP INC
13F
Company
0.64%
185,697
$814,000 31 Dec 2017
13F
BAKER BROS. ADVISORS LP
13F
Company
0.43%
125,000
$548,000 31 Dec 2017
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.27%
78,100
$342,000 31 Dec 2017
13F
UNITED SERVICES AUTOMOBILE ASSOCIATION
13F
Company
0.21%
59,990
$263,000 31 Dec 2017
13F
ROYCE & ASSOCIATES LP
13F
Company
0.17%
50,011
$219,000 31 Dec 2017
13F
THOMPSON DAVIS & CO., INC.
13F
Company
0.12%
35,234
$154,000 31 Dec 2017
13F
BlackRock Finance, Inc.
13F
Company
0.06%
15,957
$70,000 31 Dec 2017
13F
MORGAN STANLEY
13F
Company
0.01%
4,185
$18,000 31 Dec 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
2,943
$13,000 31 Dec 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
500
$2,000 31 Dec 2017
13F
UBS Group AG
13F
Company
0%
400
$2,000 31 Dec 2017
13F
ROYAL BANK OF CANADA
13F
Company
0%
300
$1,000 31 Dec 2017
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0%
180
$1,000 31 Dec 2017
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
1
$4 31 Dec 2017
13F

Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q1 2018

As of 31 Mar 2018, Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,449,767 shares. The largest 10 holders included Mutual Advisors, LLC, Old West Investment Management, LLC, VANGUARD GROUP INC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, BAKER BROS. ADVISORS LP, BRIDGEWAY CAPITAL MANAGEMENT INC, ROYCE & ASSOCIATES LP, DIMENSIONAL FUND ADVISORS LP, THOMPSON DAVIS & CO., INC., and BlackRock Inc.. This page lists 18 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
16
Q1 2018 holders
18
Holder diff
2
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 Value $ Q1 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .